AFLURIA TRIVALENT 2024-25 (influenza virus vaccine trivalent 2024-25 (6 mos and older))


Drug overview for AFLURIA TRIVALENT 2024-25 (influenza virus vaccine trivalent 2024-25 (6 mos and older)):

Generic name: INFLUENZA VIRUS VACCINE TRIVALENT 2024-25 (6 MOS AND OLDER) (IN-floo-EN-za)
Drug class: Influenza Vaccine
Therapeutic class: Biologicals

No enhanced Introduction information available for this drug.

 No enhanced Uses information available for this drug.
DRUG IMAGES
  • No Image Available
    No Image Available
The following indications for AFLURIA TRIVALENT 2024-25 (influenza virus vaccine trivalent 2024-25 (6 mos and older)) have been approved by the FDA:

Indications:
Influenza vaccination

Professional Synonyms:
Vaccination to prevent influenza